Taxol Alternatives Compared
| Taxol | Nivolumab | Exkivity |
|
|---|
| Taxol (paclitaxel) | Nivolumab | Exkivity (mobocertinib) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor. Taxol may also be used for purposes not... View more |
Prescription only
Prescribed for Esophageal Carcinoma, Head and Neck Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma - Metastatic, Non-Small... View more |
Prescription only
Prescribed for Non-Small Cell Lung Cancer. Exkivity may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Taxol (paclitaxel) | More about Nivolumab | More about Exkivity (mobocertinib) | ||||||||
| Generic Status | ||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||
| Ratings & Reviews | ||||||||||
|
Taxol has an average rating of 7.8 out of 10 from a total of 7 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Nivolumab has an average rating of 4.5 out of 10 from a total of 102 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 58% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
|
See also: Taxol side effects in more detail. |
See also: nivolumab side effects in more detail. |
See also: Exkivity side effects in more detail. |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Exkivity prices |
||||||||
| Dosage Form(s) Available | ||||||||||
|
N/A |
N/A |
|
||||||||
| Brand Names | ||||||||||
|
N/A |
Opdivo |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
17.4 hours |
640.8 hours |
N/A |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 408 drugs are known to interact with Taxol:
|
A total of 15 drugs are known to interact with nivolumab:
|
A total of 473 drugs are known to interact with Exkivity:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
December 29, 1992 |
December 22, 2014 |
September 15, 2021 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
|
N/A |
||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.